{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:12:11Z","timestamp":1791493931624,"version":"4.3.4"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In the era of combination antiretroviral therapy (ART), the incidence, manifestations and severity of kidney diseases have dramatically changed in people living with HIV (PLWH). Little is known about the incidence of impaired kidney function (IKF) measured by serum creatine-based estimated glomerular filtration rate (eGFR) in PLWH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this systematic review and meta-analysis, we searched PubMed, Ovid, Medline, Embase and Web of Science for studies published before May 7th, 2021, with estimates of incidence of IKF among PLWH. We independently reviewed each study for quality by using the Newcastle-Ottawa scale. The incidence and 95% confidence intervals (CIs) were calculated using random-effects model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Sixty out of 3797 identifiable studies were eligible for the meta-analysis. A total of 19 definitions of IKF were described and categorized into three types: the threshold of eGFR, an absolute or percent decrease in eGFR, and certain eGFR threshold combined with decrement in eGFR. The eGFR&lt;\u200960\u2009ml\/min\/1.73m<jats:sup>2<\/jats:sup> was the most widely used definition or criterion for IKF, by which the pooled incidence rate of IKF was 12.50 (95%CI: 9.00\u201317.36) per 1000 person years (PYs). The second most-studied outcome was a\u2009&gt;\u200925% decrease in eGFR, followed by eGFR&lt;\u200990\u2009ml\/min\/1.73m<jats:sup>2<\/jats:sup>, eGFR&lt;\u200930\u2009ml\/min\/1.73m<jats:sup>2<\/jats:sup> and a combination of eGFR threshold plus decreased eGFR. The reported incidence rates of IKF differ widely by different definitions of IKF. The highest pooled incidence was observed for those with &gt;\u200925% decrease in eGFR, while the lowest was observed in those with eGFR &lt;\u200930\u2009ml\/min\/1.73m<jats:sup>2<\/jats:sup>. Substantial heterogeneity was identified across most estimates.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study provides a comprehensive summary of eGFR-based definitions and incidence rates of IKF in PLWH, not only promoting our understanding of IKF, but also underscoring needs for a concerted action to unify definitions and outcomes of IKF and their applications in AIDS care.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-022-02721-x","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T16:36:02Z","timestamp":1647534962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Incidence of impaired kidney function among people with HIV: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Ruizi","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,17]]},"reference":[{"key":"2721_CR1","unstructured":"Global HIV & AIDS Statistics \u2014 2021 Fact sheet. Joint United Nations Programme on HIV\/AIDS [https:\/\/www.unaids.org\/en\/resources\/fact-sheet.]"},{"issue":"6","key":"2721_CR2","first-page":"391","volume":"10","author":"T B\u00e4rnighausen","year":"2015","unstructured":"B\u00e4rnighausen T. The HIV treatment cascade and antiretroviral impact in different populations. Curr Opin HIV AIDS. 2015;10(6):391\u20134.","journal-title":"Curr Opin HIV AIDS"},{"issue":"8","key":"2721_CR3","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.1016\/S2352-3018(16)30087-X","volume":"3","author":"Estimates of global, Regional, and national incidence, prevalence, and mortality of HIV, 1980-2015","year":"2016","unstructured":"Estimates of global, Regional, and national incidence, prevalence, and mortality of HIV, 1980-2015. The global burden of disease study 2015. Lancet HIV. 2016;3(8):e361\u201387.","journal-title":"Lancet HIV"},{"issue":"1","key":"2721_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1053\/j.ackd.2009.07.014","volume":"17","author":"MM Estrella","year":"2010","unstructured":"Estrella MM, Fine DM. Screening for chronic kidney disease in HIV-infected patients. Adv Chronic Kidney Dis. 2010;17(1):26\u201335.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"3","key":"2721_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.7326\/0003-4819-139-3-200308050-00011","volume":"139","author":"PL Kimmel","year":"2003","unstructured":"Kimmel PL, Barisoni L, Kopp JB. Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations. Ann Intern Med. 2003;139(3):214\u201326.","journal-title":"Ann Intern Med"},{"issue":"10225","key":"2721_CR6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"Collaboration GCKD","year":"2020","unstructured":"Collaboration GCKD. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709\u201333.","journal-title":"Lancet"},{"issue":"3","key":"2721_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nrneph.2015.9","volume":"11","author":"AZ Rosenberg","year":"2015","unstructured":"Rosenberg AZ, Naicker S, Winkler CA, Kopp JB. HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment. Nat Rev Nephrol. 2015;11(3):150\u201360.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"2721_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nrneph.2015.216","volume":"12","author":"E Nobakht","year":"2016","unstructured":"Nobakht E, Cohen SD, Rosenberg AZ, Kimmel PL. HIV-associated immune complex kidney disease. Nat Rev Nephrol. 2016;12(5):291\u2013300.","journal-title":"Nat Rev Nephrol"},{"issue":"24","key":"2721_CR9","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1056\/NEJMra1508467","volume":"377","author":"SD Cohen","year":"2017","unstructured":"Cohen SD, Kopp JB, Kimmel PL. Kidney diseases associated with human immunodeficiency virus infection. N Engl J Med. 2017;377(24):2363\u201374.","journal-title":"N Engl J Med"},{"issue":"3","key":"2721_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.kint.2017.11.007","volume":"93","author":"CR Swanepoel","year":"2018","unstructured":"Swanepoel CR, Atta MG, D'Agati VD, Estrella MM, Fogo AB, Naicker S, et al. Kidney disease in the setting of HIV infection: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2018;93(3):545\u201359.","journal-title":"Kidney Int"},{"issue":"5","key":"2721_CR11","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.kint.2020.01.018","volume":"97","author":"S Kudose","year":"2020","unstructured":"Kudose S, Santoriello D, Bomback AS, Stokes MB, Batal I, Markowitz GS, et al. The spectrum of kidney biopsy findings in HIV-infected patients in the modern era. Kidney Int. 2020;97(5):1006\u201316.","journal-title":"Kidney Int"},{"issue":"3","key":"2721_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/QAD.0b013e3283359253","volume":"24","author":"E George","year":"2010","unstructured":"George E, Lucas GM, Nadkarni GN, Fine DM, Moore R, Atta MG. Kidney function and the risk of cardiovascular events in HIV-1-infected patients. AIDS. 2010;24(3):387\u201394.","journal-title":"AIDS"},{"issue":"4","key":"2721_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1053\/j.ajkd.2012.03.006","volume":"60","author":"F Ibrahim","year":"2012","unstructured":"Ibrahim F, Hamzah L, Jones R, Nitsch D, Sabin C, Post FA. Baseline kidney function as predictor of mortality and kidney disease progression in HIV-positive patients. Am J Kidney Dis. 2012;60(4):539\u201347.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2721_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"A Levin","year":"2013","unstructured":"Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco ALM, De Jong PE, et al. Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1\u2013150.","journal-title":"Kidney Int Suppl"},{"issue":"3","key":"2721_CR15","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/QAI.0b013e31826a6c4f","volume":"61","author":"LA Inker","year":"2012","unstructured":"Inker LA, Wyatt C, Creamer R, Hellinger J, Hotta M, Leppo M, et al. Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals. J Acquir Immune Defic Syndr. 2012;61(3):302\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2721_CR16","doi-asserted-by":"crossref","unstructured":"Ekrikpo UE, Kengne AP, Bello AK, Effa EE, Noubiap JJ, Salako BL, et al. Chronic kidney disease in the global adult HIV-infected population: a systematic review and meta-analysis. PLoS One. 2018;13(4).","DOI":"10.1371\/journal.pone.0195443"},{"issue":"1","key":"2721_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2288-14-25","volume":"14","author":"J IntHout","year":"2014","unstructured":"IntHout J, Ioannidis JPA, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol. 2014;14(1):25.","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"2721_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/QAI.0b013e3181e8d5a8","volume":"55","author":"GM Lucas","year":"2010","unstructured":"Lucas GM, Clarke W, Kagaayi J, Atta MG, Fine DM, Laeyendecker O, et al. Decreased kidney function in a community-based cohort of HIV-infected and HIV-negative individuals in Rakai, Uganda. J Acquir Immune Defic Syndr Hum Retrovirol. 2010;55(4):491\u20134.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"5","key":"2721_CR19","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1177\/0897190012442718","volume":"25","author":"MO Monteagudo-Chu","year":"2012","unstructured":"Monteagudo-Chu MO, Chang MH, Fung HB, Brau N. Renal toxicity of long-term therapy with tenofovir in HIV-infected patients. J Pharm Pract. 2012;25(5):552\u20139.","journal-title":"J Pharm Pract"},{"issue":"4","key":"2721_CR20","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/cid\/cis937","volume":"56","author":"C Laprise","year":"2013","unstructured":"Laprise C, Baril JG, Dufresne S, Trottier H. Association between tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up. Clin Infect Dis. 2013;56(4):567\u201375.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2721_CR21","doi-asserted-by":"publisher","first-page":"ofy072","DOI":"10.1093\/ofid\/ofy072","volume":"5","author":"H Mapesi","year":"2018","unstructured":"Mapesi H, Kalinjuma AV, Ngerecha A, Franzeck F, Hatz C, Tanner M, et al. Prevalence and evolution of renal impairment in people living with HIV in rural Tanzania. Open Forum Infect Dis. 2018;5(4):ofy072.","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"2721_CR22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/hiv.12763","volume":"20","author":"Y Ding","year":"2019","unstructured":"Ding Y, Duan S, Ye R, Yao S, Cao D, Yang Y, et al. Effects of aging, baseline renal function and stage of HIV infection on post-treatment changes in renal function among HIV-infected patients: a retrospective cohort study. HIV Med. 2019;20(9):591\u2013600.","journal-title":"HIV Med"},{"key":"2721_CR23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/TCRM.S243913","volume":"16","author":"F Liu","year":"2020","unstructured":"Liu F, Xu A, Zhao H, Yang Z, Chen C, Ranieri B, et al. Longitudinal progression of estimated GFR in HIV-1-infected patients with normal renal function on tenofovir-based therapy in China. Ther Clin Risk Manag. 2020;16:299\u2013310.","journal-title":"Ther Clin Risk Manag"},{"issue":"7","key":"2721_CR24","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1097\/QAD.0b013e328351f68f","volume":"26","author":"R Scherzer","year":"2012","unstructured":"Scherzer R, Estrella M, Li Y, Choi AI, Deeks SG, Grunfeld C, et al. Association of tenofovir exposure with kidney disease risk in HIV infection. AIDS. 2012;26(7):867\u201375.","journal-title":"AIDS"},{"issue":"8","key":"2721_CR25","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1097\/QAD.0000000000001041","volume":"30","author":"H Zachor","year":"2016","unstructured":"Zachor H, Machekano R, Estrella MM, Veldkamp PJ, Zeier MD, Uthman OA, et al. Incidence of stage 3 chronic kidney disease and progression on tenofovir-based regimens. AIDS. 2016;30(8):1221\u20138.","journal-title":"AIDS"},{"issue":"11","key":"2721_CR26","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1086\/587994","volume":"197","author":"GM Lucas","year":"2008","unstructured":"Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis. 2008;197(11):1548\u201357.","journal-title":"J Infect Dis"},{"issue":"6","key":"2721_CR27","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1468-1293.2008.00691.x","volume":"10","author":"LJ Campbell","year":"2009","unstructured":"Campbell LJ, Ibrahim F, Fisher M, Holt SG, Hendry BM, Post FA. Spectrum of chronic kidney disease in HIV-infected patients. HIV Med. 2009;10(6):329\u201336.","journal-title":"HIV Med"},{"issue":"7","key":"2721_CR28","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.2215\/CJN.09191010","volume":"6","author":"P Flandre","year":"2011","unstructured":"Flandre P, Pugliese P, Cuzin L, Bagnis CI, Tack I, Cabie A, et al. Risk factors of chronic kidney disease in HIV-infected patients. Clin J Am Soc Nephrol. 2011;6(7):1700\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"2721_CR29","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3109\/00365548.2012.673730","volume":"44","author":"MG Rasch","year":"2012","unstructured":"Rasch MG, Engsig FN, Feldt-Rasmussen B, Kirk O, Kronborg G, Pedersen C, et al. Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study. Scand J Infect Dis. 2012;44(9):689\u201396.","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"2721_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4172\/jaa.1000041","volume":"4","author":"N Rockwood","year":"2012","unstructured":"Rockwood N, Mandalia S, Sirsokosta J, Gazzard B, Nelson M. A comparative analysis of risk factors associated with renal impairment and highly active antiretroviral therapy. J Antivir Antiretrovir. 2012;4(2):21\u20135.","journal-title":"J Antivir Antiretrovir"},{"issue":"15","key":"2721_CR31","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1097\/QAD.0b013e328357f5ed","volume":"26","author":"RC Kalayjian","year":"2012","unstructured":"Kalayjian RC, Lau B, Mechekano RN, Crane HM, Rodriguez B, Salata RA, et al. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. AIDS. 2012;26(15):1907\u201315.","journal-title":"AIDS"},{"issue":"2","key":"2721_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1468-1293.2012.01036.x","volume":"14","author":"A Ganesan","year":"2013","unstructured":"Ganesan A, Krantz EM, Hullsiek KH, Riddle MS, Weintrob AC, Lalani T, et al. Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care. HIV Med. 2013;14(2):65\u201376.","journal-title":"HIV Med"},{"issue":"6","key":"2721_CR33","doi-asserted-by":"publisher","first-page":"e66223","DOI":"10.1371\/journal.pone.0066223","volume":"8","author":"P Morlat","year":"2013","unstructured":"Morlat P, Vivot A, Vandenhende MA, Dauchy FA, Asselineau J, D\u00e9ti E, et al. \u3010\u5371\u9669\u56e0\u7d20-\u8bf8\u591a\u3011role of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012. PLoS One. 2013;8(6):e66223.","journal-title":"PLoS One"},{"issue":"8","key":"2721_CR34","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1093\/infdis\/jit373","volume":"208","author":"GM Lucas","year":"2013","unstructured":"Lucas GM, Jing Y, Sulkowski M, Abraham AG, Estrella MM, Atta MG, et al. Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals. J Infect Dis. 2013;208(8):1240\u20139.","journal-title":"J Infect Dis"},{"issue":"9","key":"2721_CR35","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1097\/QAD.0000000000000258","volume":"28","author":"R Scherzer","year":"2014","unstructured":"Scherzer R, Gandhi M, Estrella MM, Tien PC, Deeks SG, Grunfeld C, et al. A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans. AIDS. 2014;28(9):1289\u201395.","journal-title":"AIDS"},{"key":"2721_CR36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1471-2334-14-173","volume":"14","author":"SN Pujari","year":"2014","unstructured":"Pujari SN, Smith C, Makane A, Youle M, Johnson M, Bele V, et al. Higher risk of renal impairment associated with tenofovir use amongst people living with HIV in India: a comparative cohort analysis between Western India and United Kingdom. BMC Infect Dis. 2014;14:173.","journal-title":"BMC Infect Dis"},{"issue":"13","key":"2721_CR37","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1097\/QAD.0000000000000347","volume":"28","author":"T Nishijima","year":"2014","unstructured":"Nishijima T, Kawasaki Y, Tanaka N, Mizushima D, Aoki T, Watanabe K, et al. Long-term exposure to tenofovir continuously decrease renal function in HIV-1-infected patients with low body weight: results from 10 years of follow-up. AIDS. 2014;28(13):1903\u201310.","journal-title":"AIDS"},{"issue":"5","key":"2721_CR38","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s11096-015-0132-1","volume":"37","author":"PR Quesada","year":"2015","unstructured":"Quesada PR, Esteban LL, Garcia JR, Sanchez RV, Garcia TM, Alonso-Vega GG, et al. Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients. Int J Clin Pharm. 2015;37(5):865\u201372.","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"2721_CR39","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/cid\/ciu765","volume":"60","author":"MM Estrella","year":"2015","unstructured":"Estrella MM, Li M, Tin A, Abraham AG, Shlipak MG, Penugonda S, et al. The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status. Clin Infect Dis. 2015;60(4):646\u201352.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2721_CR40","doi-asserted-by":"publisher","first-page":"e0162320","DOI":"10.1371\/journal.pone.0162320","volume":"11","author":"G Lapadula","year":"2016","unstructured":"Lapadula G, Bernasconi DP, Casari S, Maggiolo F, Cauda R, Di Pietro M, et al. Risk of chronic kidney disease among patients developing mild renal impairment during Tenofovir-containing antiretroviral treatment. PLoS ONE [Electronic Resource]. 2016;11(9):e0162320.","journal-title":"PLoS ONE [Electronic Resource]"},{"issue":"10","key":"2721_CR41","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1097\/QAD.0000000000001070","volume":"30","author":"T Nishijima","year":"2016","unstructured":"Nishijima T, Kurosawa T, Tanaka N, Kawasaki Y, Kikuchi Y, Oka S, et al. Urinary beta2 microglobulin can predict tenofovir disoproxil fumarate-related renal dysfunction in HIV-1-infected patients who initiate tenofovir disoproxil fumarate-containing antiretroviral therapy. AIDS. 2016;30(10):1563\u201371.","journal-title":"AIDS"},{"issue":"2","key":"2721_CR42","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10157-016-1281-9","volume":"21","author":"M Hara","year":"2017","unstructured":"Hara M, Yanagisawa N, Ohta A, Momoki K, Tsuchiya K, Nitta K, et al. Increased non-HDL-C level linked with a rapid rate of renal function decline in HIV-infected patients. Clin Exp Nephrol. 2017;21(2):275\u201382.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"2721_CR43","doi-asserted-by":"publisher","first-page":"21317","DOI":"10.7448\/IAS.20.01\/21317","volume":"20","author":"R De Waal","year":"2017","unstructured":"De Waal R, Cohen K, Fox MP, Stinson K, Maartens G, Boulle A, et al. Changes in estimated glomerular filtration rate over time in south African HIV-1-infected patients receiving tenofovir: a retrospective cohort study. J Int AIDS Soc. 2017;20(1):21317.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"2721_CR44","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12879-017-2350-8","volume":"17","author":"C Rossi","year":"2017","unstructured":"Rossi C, Raboud J, Walmsley S, Cooper C, Antoniou T, Burchell AN, et al. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy. BMC Infect Dis. 2017;17(1):246.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"2721_CR45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1089\/apc.2016.0286","volume":"31","author":"S Suzuki","year":"2017","unstructured":"Suzuki S, Nishijima T, Kawasaki Y, Kurosawa T, Mutoh Y, Kikuchi Y, et al. Effect of Tenofovir Disoproxil fumarate on incidence of chronic kidney disease and rate of estimated glomerular filtration rate decrement in HIV-1-infected treatment-Na\u00efve Asian patients: results from 12-year observational cohort. AIDS Patient Care STDs. 2017;31(3):105\u201312.","journal-title":"AIDS Patient Care STDs"},{"issue":"4","key":"2721_CR46","first-page":"459","volume":"64","author":"C Wong","year":"2017","unstructured":"Wong C, Gange SJ, Buchacz K, Moore RD, Justice AC, Horberg MA, et al. First occurrence of diabetes, chronic kidney disease, and hypertension among north American HIV-infected adults, 2000-2013. Clin Infect Dis. 2017;64(4):459\u201367.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2721_CR47","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.ekir.2018.04.014","volume":"3","author":"Y Bouatou","year":"2018","unstructured":"Bouatou Y, Ageron AG, Bernasconi E, Battegay M, Hoffmann M, Staehelin C, et al. Lipodystrophy increases the risk of CKD development in HIV-positive patients in Switzerland: the LIPOKID study. Kidney Int Rep. 2018;3(5):1089\u201399.","journal-title":"Kidney Int Rep"},{"issue":"8","key":"2721_CR48","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/nep.13100","volume":"23","author":"J Cheung","year":"2018","unstructured":"Cheung J, Puhr R, Petoumenos K, Cooper DA, Woolley I, Gunathilake M, et al. Chronic kidney disease in Australian human immunodeficiency virus-infected patients: analysis of the Australian HIV observational database. Nephrology. 2018;23(8):778\u201386.","journal-title":"Nephrology"},{"issue":"11","key":"2721_CR49","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1093\/infdis\/jiy397","volume":"218","author":"R Jones","year":"2018","unstructured":"Jones R, Hamzah L, Williams D, Winston A, Burns F, Phillips AN, et al. Chronic kidney disease risk in African and Caribbean populations with HIV. J Infect Dis. 2018;218(11):1767\u201372.","journal-title":"J Infect Dis"},{"issue":"11","key":"2721_CR50","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/pds.4657","volume":"27","author":"K Joshi","year":"2018","unstructured":"Joshi K, Boettiger D, Kerr S, Nishijima T, Van Nguyen K, Ly PS, et al. Changes in renal function with long-term exposure to antiretroviral therapy in HIV-infected adults in Asia. Pharmacoepidemiol Drug Saf. 2018;27(11):1209\u201316.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"13","key":"2721_CR51","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1097\/QAD.0000000000001901","volume":"32","author":"EL Woolnough","year":"2018","unstructured":"Woolnough EL, Hoy JF, Cheng AC, Walker RG, Chrysostomou A, Woolley I, et al. Predictors of chronic kidney disease and utility of risk prediction scores in HIV-positive individuals. AIDS. 2018;32(13):1829\u201335.","journal-title":"AIDS"},{"issue":"3","key":"2721_CR52","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/QAD.0000000000001698","volume":"32","author":"W Pongpirul","year":"2018","unstructured":"Pongpirul W, Pongpirul K, Ananworanich J, Klinbuayaem V, Avihingsanon A, Prasithsirikul W. \u3010\u5371\u9669\u56e0\u7d20-DM\/\u9ad8TC\/age\/VL\u3011chronic kidney disease incidence and survival of Thai HIV-infected patients. AIDS. 2018;32(3):393\u20138.","journal-title":"AIDS"},{"issue":"2","key":"2721_CR53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.18683\/germs.2018.1133","volume":"8","author":"BV Ojeh","year":"2018","unstructured":"Ojeh BV, Abah IO, Ugoagwu P, Agaba PA, Agbaji OO, Gyang SS. Incidence and predictors of tenofovir disoproxil fumarate-induced renal impairment in HIV infected nigerian patients. Germs. 2018;8(2):67\u201376.","journal-title":"Germs"},{"issue":"3","key":"2721_CR54","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s10157-018-1644-5","volume":"23","author":"B Mat\u0142osz","year":"2019","unstructured":"Mat\u0142osz B, Pietraszkiewicz E, Firl\u0105g-Burkacka E, Grycner E, Horban A, Kowalska JD. Risk factors for kidney disease among HIV-1 positive persons in the methadone program. Clin Exp Nephrol. 2019;23(3):342\u20138.","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"2721_CR55","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/cid\/ciu869","volume":"60","author":"KN Althoff","year":"2015","unstructured":"Althoff KN, McGinnis KA, Wyatt CM, Freiberg MS, Gilbert C, Oursler KK, et al. Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults. Clin Infect Dis. 2015;60(4):627\u201338.","journal-title":"Clin Infect Dis"},{"key":"2721_CR56","doi-asserted-by":"crossref","unstructured":"Kabore NF, Poda A, Zoungrana J, Da O, Ciaffi L, Semde A, et al. Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting. BMC Nephrol. 2019;20.","DOI":"10.1186\/s12882-019-1335-9"},{"issue":"5","key":"2721_CR57","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.nefro.2019.01.009","volume":"39","author":"P Domingo","year":"2019","unstructured":"Domingo P, Suarez-Lozano I, Gutierrez F, Estrada V, Knobel H, Palacios R, et al. Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: results from the VACH longitudinal cohort study. Nefrologia. 2019;39(5):497\u2013505.","journal-title":"Nefrologia"},{"issue":"1","key":"2721_CR58","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1097\/QAI.0000000000001999","volume":"81","author":"EF Eaton","year":"2019","unstructured":"Eaton EF, Tamhane A, Davy-Mendez T, Moore RD, Mathews WC, Saag MS, et al. Brief report: kidney dysfunction does not contribute significantly to antiretroviral therapy modification in treatment-naive PLWH receiving initial ART. J Acquir Immune Defic Syndr. 2019;81(1):e6\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"2721_CR59","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/hiv.12826","volume":"21","author":"AM Mills","year":"2020","unstructured":"Mills AM, Schulman KL, Fusco JS, Brunet L, Hsu R, Beyer A, et al. Validation of the data collection on adverse events of anti-HIV drugs (D:a:D) chronic kidney disease risk score in HIV-infected patients in the USA. HIV Med. 2020;21(5):299\u2013308.","journal-title":"HIV Med"},{"issue":"4","key":"2721_CR60","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/QAI.0000000000002464","volume":"85","author":"WM Han","year":"2020","unstructured":"Han WM, Bijker R, Chandrasekaran E, Pujari S, Ng OT, Ly PS, et al. Validation of the D: a: D chronic kidney disease risk score model among people living with HIV in the Asia-Pacific. J Acquir Immune Defic Syndr. 2020;85(4):489\u201397.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"2721_CR61","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/QAI.0b013e31825b70d9","volume":"60","author":"RK Medapalli","year":"2012","unstructured":"Medapalli RK, Parikh CR, Gordon K, Brown ST, Butt AA, Gibert CL, et al. Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the veterans aging cohort study. J Acquir Immune Defic Syndr. 2012;60(4):393\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"2721_CR62","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1089\/apc.2016.0286","volume":"31","author":"S Suzuki","year":"2017","unstructured":"Suzuki S, Nishijima T, Kawasaki Y, Kurosawa T, Mutoh Y, Kikuchi Y, et al. Effect of tenofovir disoproxil fumarate on incidence of chronic kidney disease and rate of estimated glomerular filtration rate decrement in HIV-1-infected treatment-naive Asian patients: results from 12-year observational cohort. AIDS Patient Care STDs. 2017;31(3):105\u201312.","journal-title":"AIDS Patient Care STDs"},{"issue":"7","key":"2721_CR63","doi-asserted-by":"publisher","first-page":"504","DOI":"10.2174\/157016210793499259","volume":"8","author":"K Chaisiri","year":"2010","unstructured":"Chaisiri K, Bowonwatanuwong C, Kasettratat N, Kiertiburanakul S. Incidence and risk factors for tenofovir-associated renal function decline among Thai HIV-infected patients with low-body weight. Curr HIV Res. 2010;8(7):504\u20139.","journal-title":"Curr HIV Res"},{"issue":"7","key":"2721_CR64","doi-asserted-by":"publisher","first-page":"e22661","DOI":"10.1371\/journal.pone.0022661","volume":"6","author":"T Nishijima","year":"2011","unstructured":"Nishijima T, Komatsu H, Gatanaga H, Aoki T, Watanabe K, Kinai E, et al. Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients. PLoS One. 2011;6(7):e22661.","journal-title":"PLoS One"},{"issue":"1","key":"2721_CR65","doi-asserted-by":"publisher","first-page":"e29977","DOI":"10.1371\/journal.pone.0029977","volume":"7","author":"T Nishijima","year":"2012","unstructured":"Nishijima T, Gatanaga H, Komatsu H, Tsukada K, Shimbo T, Aoki T, et al. Renal function declines more in tenofovir- than abacavir-based antiretroviral therapy in low-body weight treatment-na\u00efve patients with HIV infection. PLoS One. 2012;7(1):e29977.","journal-title":"PLoS One"},{"issue":"6","key":"2721_CR66","first-page":"308","volume":"71","author":"HM Koh","year":"2016","unstructured":"Koh HM, Suresh K. Tenofovir-induced nephrotoxicity: a retrospective cohort study. Med J Malaysia. 2016;71(6):308\u201312.","journal-title":"Med J Malaysia"},{"issue":"2","key":"2721_CR67","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3904\/kjim.2016.418","volume":"34","author":"JE Lee","year":"2019","unstructured":"Lee JE, Lee S, Song SH, Kwak IS, Lee SH. Incidence and risk factors for tenofovir-associated nephrotoxicity among human immunodeficiency virus-infected patients in Korea. Korean J Intern Med. 2019;34(2):409\u201317.","journal-title":"Korean J Intern Med"},{"issue":"3","key":"2721_CR68","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/jppr.1392","volume":"48","author":"JZ Low","year":"2018","unstructured":"Low JZ, Khoo SP, Nor Azmi N, Chong ML, Sulaiman H, Azwa I, et al. Is the risk of tenofovir-induced nephrotoxicity similar in treatment-naive compared to treatment-experienced patients? J Pharm Pract Res. 2018;48(3):242\u201350.","journal-title":"J Pharm Pract Res"},{"issue":"10","key":"2721_CR69","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1097\/QAD.0000000000002570","volume":"34","author":"A Mocroft","year":"2020","unstructured":"Mocroft A, Ryom L, Oprea C, Li Q, Rauch A, Boesecke C, et al. Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons. AIDS. 2020;34(10):1485\u201395.","journal-title":"AIDS"},{"issue":"10","key":"2721_CR70","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1080\/03007995.2020.1816538","volume":"36","author":"SS Sutton","year":"2020","unstructured":"Sutton SS, Magagnoli J, Hardin JW, Hsu LI, Beaubrun A, Majethia S, et al. Association of tenofovir disoproxil fumarate exposure with chronic kidney disease and osteoporotic fracture in US veterans with HIV. Curr Med Res Opin. 2020;36(10):1635\u201342.","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"2721_CR71","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jmii.2019.07.003","volume":"52","author":"Q Tan","year":"2019","unstructured":"Tan Q, He YH, Yang TT, Yan DM, Wang Y, Zhao X, et al. Effects of long-term exposure to tenofovir disoproxil fumarate-containing antiretroviral therapy on renal function in HIV-positive Chinese patients. J Microbiol Immunol Infect. 2019;52(5):710\u20139.","journal-title":"J Microbiol Immunol Infect"},{"issue":"12","key":"2721_CR72","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.2215\/CJN.00520110","volume":"5","author":"TP Alves","year":"2010","unstructured":"Alves TP, Hulgan T, Wu P, Sterling TR, Stinnette SE, Rebeiro PF, et al. Race, kidney disease progression, and mortality risk in HIV-infected persons. Clin J Am Soc Nephrol. 2010;5(12):2269\u201375.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2721_CR73","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/QAI.0b013e3181be6be2","volume":"53","author":"M Horberg","year":"2010","unstructured":"Horberg M, Tang B, Towner W, Silverberg M, Bersoff-Matcha S, Hurley L, et al. Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients. J Acquir Immune Defic Syndr. 2010;53(1):62\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"2721_CR74","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s10157-010-0393-x","volume":"15","author":"M Ando","year":"2011","unstructured":"Ando M, Yanagisawa N, Ajisawa A, Tsuchiya K, Nitta K. A simple model for predicting incidence of chronic kidney disease in HIV-infected patients. Clin Exp Nephrol. 2011;15(2):242\u20137.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"2721_CR75","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1468-1293.2010.00855.x","volume":"12","author":"F Tordato","year":"2011","unstructured":"Tordato F, Cozzi Lepri A, Cicconi P, De Luca A, Antinori A, Colangeli V, et al. Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure. HIV Med. 2011;12(1):4\u201313.","journal-title":"HIV Med"},{"key":"2721_CR76","unstructured":"Dietrich LG, Thorball CW, Ryom L, Burkhalter F, Hasse B, Thurnheer MC, et al. Rapid Progression of Kidney Dysfunction in Swiss People Living with HIV: Contribution of Polygenic Risk Score and D:A:D Clinical Risk Score. J Infect Dis. 2020;05."},{"issue":"2","key":"2721_CR77","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/pds.5125","volume":"30","author":"F Kalemeera","year":"2021","unstructured":"Kalemeera F, Godman B, Stergachis A, Rennie T. Tenofovir disoproxil fumarate associated nephrotoxicity: a retrospective cohort study at two referral hospitals in Namibia. Pharmacoepidemiol Drug Saf. 2021;30(2):189\u2013200.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"2721_CR78","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/tmi.12446","volume":"20","author":"M Kamkuemah","year":"2015","unstructured":"Kamkuemah M, Kaplan R, Bekker LG, Little F, Myer L. Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a primary healthcare setting in South Africa. Tropical Med Int Health. 2015;20(4):518\u201326.","journal-title":"Tropical Med Int Health"},{"issue":"12","key":"2721_CR79","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.5551\/jat.47779","volume":"26","author":"H Sonoda","year":"2019","unstructured":"Sonoda H, Nakamura K, Tamakoshi A. Ankle-brachial index is a predictor of future incident chronic kidney disease in a general Japanese population. J Atheroscler Thromb. 2019;26(12):1054\u201361.","journal-title":"J Atheroscler Thromb"},{"issue":"6","key":"2721_CR80","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/hiv.13077","volume":"22","author":"NA Jespersen","year":"2021","unstructured":"Jespersen NA, Axelsen F, Dollerup J, N\u00f8rgaard M, Larsen CS. The burden of non-communicable diseases and mortality in people living with HIV (PLHIV) in the pre-, early- and late-HAART era. HIV Med. 2021;22(6):478\u201390.","journal-title":"HIV Med"},{"issue":"4","key":"2721_CR81","doi-asserted-by":"publisher","first-page":"R204","DOI":"10.1186\/cc2872","volume":"8","author":"R Bellomo","year":"2004","unstructured":"Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute Dialysis quality initiative (ADQI) group. Crit Care. 2004;8(4):R204\u201312.","journal-title":"Crit Care"},{"issue":"5","key":"2721_CR82","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.kint.2017.06.030","volume":"92","author":"L He","year":"2017","unstructured":"He L, Wei Q, Liu J, Yi M, Liu Y, Liu H, et al. AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms. Kidney Int. 2017;92(5):1071\u201383.","journal-title":"Kidney Int"},{"issue":"8","key":"2721_CR83","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1093\/ndt\/gft210","volume":"28","author":"P Wikman","year":"2013","unstructured":"Wikman P, Safont P, Del Palacio M, Moreno A, Moreno S, Casado JL. The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients. Nephrol Dial Transplant. 2013;28(8):2073\u201381.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"2721_CR84","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/QAD.0000000000001353","volume":"31","author":"S Jose","year":"2017","unstructured":"Jose S, Nelson M, Phillips A, Chadwick D, Trevelion R, Jones R, et al. Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir. AIDS. 2017;31(4):485\u201392.","journal-title":"AIDS"},{"issue":"11","key":"2721_CR85","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1089\/aid.2009.0261","volume":"26","author":"P De Beaudrap","year":"2010","unstructured":"De Beaudrap P, Diallo MB, Landman R, Gueye NF, Ndiaye I, Diouf A, et al. Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215). AIDS Res Hum Retrovir. 2010;26(11):1221\u20137.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"24","key":"2721_CR86","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1001\/jama.2014.6634","volume":"311","author":"J Coresh","year":"2014","unstructured":"Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014;311(24):2518\u201331.","journal-title":"JAMA"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02721-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-02721-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02721-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T22:07:42Z","timestamp":1666649262000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-02721-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,17]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2721"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-02721-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,17]]},"assertion":[{"value":"28 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All of the authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}